Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Preterm Infants 401-1250 Grams: Two Multi-Center, Randomized, Double-Masked, Placebo Controlled Studies

NCT01203514 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.

NCT NCT01203514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01203514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Preterm Infants 401-1250 Grams: Two Multi-Center, Randomized, Double-Masked, Placebo Controlled Studies
Lead sponsor
NICHD Neonatal Research Network
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 1997
Completion date
August 31, 2000
Enrollment
318 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, neonatal, infant, low birth weight, infant, newborn, infant, premature, infant, small for gestational age